Evidence map›Paper›PMID 27583434›Full record

ArticlePLoS genetics2016

Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.

Bo Hu, Sezgi Arpag, Xuebao Zhang, Wiebke Möbius, Hauke Werner, Gina Sosinsky, Mark Ellisman, Yang Zhang, Audra Hamilton, Jonathan Chernoff and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. PAK1 Positively Regulates Oligodendrocyte Morphology and Myelination.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. The Actin Cytoskeleton in Myelinating Cells.Neurochemical research · 2020
    Review
  16. Article
  17. Length-dependent MRI of hereditary neuropathy with liability to pressure palsies.Annals of clinical and translational neurology · 2020
    Article
  18. RUNX repressesScience advances · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Bo HuDepartment of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Sezgi ArpagDepartment of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.ORCID 0000-0002-6449-4164
Xuebao ZhangDepartment of Anatomy and Cell Biology, Wayne State University, Detroit, Michigan, United States of America.
Wiebke MöbiusCenter Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), GÖttingen, Germany.
Hauke WernerCenter Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), GÖttingen, Germany.
Gina SosinskyNational Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, California, United States of America.
Mark EllismanNational Center for Microscopy and Imaging Research, University of California, San Diego, La Jolla, California, United States of America.
Yang ZhangDepartment of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Audra HamiltonDepartment of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Jonathan ChernoffCancer Biology, Fox Chase Cancer Center, Philadelphia, United States of America.
Jun LiDepartment of Neurology, Center for Human Genetics Research, Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Vanderbilt University · USNanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 · DEUniversity of California San Diego · USFox Chase Cancer Center · USWayne State University · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
Pathophysiology of Conduction Block in HNPP.R01NS066927 · NINDS · WAYNE STATE UNIVERSITY · PI LI, JUN · 2010 to 2019
$3.5M
NCI NIH HHS P30 CA006927NIGMS NIH HHS P41 GM103412NINDS NIH HHS R01 NS066927
6 · The paper itself

Abstract

Schwann cells in the peripheral nervous systems extend their membranes to wrap axons concentrically and form the insulating sheath, called myelin. The spaces between layers of myelin are sealed by myelin junctions. This tight insulation enables rapid conduction of electric impulses (action potentials) through axons. Demyelination (stripping off the insulating sheath) has been widely regarded as one of the most important mechanisms altering the action potential propagation in many neurological diseases. However, the effective nerve conduction is also thought to require a proper myelin seal through myelin junctions such as tight junctions and adherens junctions. In the present study, we have demonstrated the disruption of myelin junctions in a mouse model (Pmp22+/-) of hereditary neuropathy with liability to pressure palsies (HNPP) with heterozygous deletion of Pmp22 gene. We observed a robust increase of F-actin in Pmp22+/- nerve regions where myelin junctions were disrupted, leading to increased myelin permeability. These abnormalities were present long before segmental demyelination at the late phase of Pmp22+/- mice. Moreover, the increase of F-actin levels correlated with an enhanced activity of p21-activated kinase (PAK1), a molecule known to regulate actin polymerization. Pharmacological inhibition of PAK normalized levels of F-actin, and completely prevented the progression of the myelin junction disruption and nerve conduction failure in Pmp22+/- mice. Our findings explain how abnormal myelin permeability is caused in HNPP, leading to impaired action potential propagation in the absence of demyelination. We call it "functional demyelination", a novel mechanism upstream to the actual stripping of myelin that is relevant to many demyelinating diseases. This observation also provides a potential therapeutic approach for HNPP.

Indexed as

ActinsAction PotentialsAnimalsArthrogryposisCells, CulturedGene DeletionHereditary Sensory and Motor NeuropathyHeterozygoteIntercellular JunctionsMiceMice, Inbred C57BLMyelin ProteinsMyelin Sheathp21-Activated KinasesProtein Kinase InhibitorsActinsMyelin Proteinsp21-Activated KinasesPak1 protein, mousePmp22 protein, mouseProtein Kinase Inhibitors

Identifiers

PMID27583434
PMCPMC5008806
OpenAlexW2510433018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.